← All trials
NCT02042001
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Sep 1, 2015
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Azienda Ospedaliera San Gerardo di MonzaLead sponsor
- Azienda Ospedaliera San Gerardo di MonzaOverall official - principal investigator
- Azienda Ospedaliera San Gerardo di MonzaStudy director
- Gilead SciencesCollaborator
- Azienda Ospedaliera San Gerardo di MonzaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.